recombinant DNA technology
英
美 [rɪˈkɑmbɪnənt ˌdiː en ˈeɪ tekˈnɑːlədʒi]
网络 DNA重组技术; 技术; 重组DNA技术; 重组; 重组 DNA技术
双语例句
- This paper introduced the expression of BMP in Pichia Pastoris using recombinant DNA technology, determined the phenotype of X-33/ pPICZ α A-BMP, optimized the growth conditions and expression conditions.
文章介绍了利用基因工程技术在酵母菌中表达BMP的方法，对构建的Pichiapastoris酵母工程菌株X-33/pPICZαA-BMP进行了发酵表达，确定了菌株的表型、高密度生长及表达条件。 - In this study, recombinant DNA technology was applied for producing recombinant human BMP-4 mature peptide.
因此本研究利用基因工程生产人BMP-4成熟肽。 - Therapeutic recombinant proteins are produced by the recombinant DNA technology.
重组药用蛋白质是指利用DNA重组技术生产的蛋白质。 - Methods: An artificial egf gene was constructed with recombinant DNA technology and inserted into pQE-40 to get a expression plasmid pQE-EGF, in which egf was fused with 6 × His tag. Plasmid pQE-EGF was transformed into E.
方法：用DNA重组技术构建EGF基因并插入表达载体pQE-40，与载体上的6×His标签融合，获得的表达质粒pQE-EGF转化E。 - Application of recombinant DNA technology in entomology
重组DNA技术在昆虫学中的应用 - Certain APIs of low molecular weight, such as antibiotics, amino acids, vitamins, and carbohydrates, can also be produced by recombinant DNA technology.
有些低分子量的原料药，如抗生素、氨基酸、维生素和糖类也可以用重组DNA来生产。 - Biochip technology is a great breakthrough of life science after recombinant DNA technology and polymerase chain reaction.
生物芯片技术是继基因工程（重组DNA技术）、聚合酶链式反应（PCR）之后在分子生物学领域中的又一重大突破。 - As recombinant DNA technology is consummating increasingly, genetic engineering drug is frequently researched and utilized.
随着重组DNA技术的不断完善，基因工程药物的研制和利用日益增多。 - Sensitive assays require a highly purified enzyme with a high turnover number, and a low detection limit for the reaction product. Diagnostic enzymes produced by recombinant DNA technology, which increased yield and quality of enzyme and simplified preparing process, improved the development of EIA greatly.
利用基因工程生产诊断用酶，使酶的纯度大大提高，产量及质量均较自然来源酶好，简化了制备程序，大大促进了酶免疫分析技术的发展。 - Prophylactic vaccines based on the use of virus-like particles ( VLPs) obtained from auto-assembly of L1 or L1 and L2 proteins produced by recombinant DNA technology are under phase I/ II clinical trials for HPV6/ 11 associated with condylomas.
通过DNA重组技术，基于HPV6/11型L1或L1和L2蛋白自我组装成病毒样颗粒的研究已经进入了I/II期临床实验。